Work

Erlotinib added to carboplatin and paclitaxel as first-line treatment of ovarian cancer: A phase II study based on surgical reassessment

Year: 2010

Type: article

Study design: Clinical Trial

Source: Gynecologic Oncology

DOI: 10.1016/j.ygyno.2010.08.008

Authors: Stephanie V. Blank, Paul Christos, John P. Curtin, Noah Goldman, Carolyn D. Runowicz, Joseph A. Sparano, Leonard Liebes, Helen X. Chen, Franco M. Muggia

Institutions: NYU Langone Health, New York University, Cornell University, Weill Cornell Medicine, UConn Health, Albert Einstein College of Medicine, Montefiore Medical Center, Montefiore Einstein Comprehensive Cancer Center, National Institutes of Health, National Cancer Institute

Language: English

Topic: Ovarian cancer diagnosis and treatment

Subfield: Reproductive Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Lynne Cohen Foundation for Ovarian Cancer Research, National Institutes of Health, National Cancer Institute, National Center for Research Resources

Awards: Early Therapeutics Development with Phase II Emphasis, G249968886, G3424222379, G509234630, General Clinical Research Center, G671773936

OpenAlex ID: W1974028385

FWCI: 6.165

Cites: 30

Cited by: 56

Related to: 10